With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...

The benchmark US stock measures were pointing higher before the opening bell Monday, clawing back some of the losses made at the end of last week as traders take positions ahead of an upcoming key ...